TrialClinical cancer research : an official journal of the American Association for Cancer Research2010

A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survival.

Richard J Barth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.